Biotech Archives - Page 696 of 795

1 minute read

Multiple Sclerosis Is A Crowded Space, But This Stock Is A Potential 6X Multi-bagger

September 19, 3:03 PM

HC Wainwright assumes coverage on Immunic Inc (NASDAQ:IMUX), a late-stage clinical biotech company developing oral small molecule inhibitors for multiple sclerosis (MS)…

IMUX

1 minute read

Analyst Builds Bullish Case For This Neuromuscular Company, Sees 200% Upside

By Vandana Singh

September 19, 2:39 PM

HC Wainwright has assumed coverage on Scholar Rock Holding Corp (NASDAQ:SRRK) with a Buy rating and price target of $30. The analyst writes…

SRRK

1 minute read

Theravance Outlines $250M Capital Return Program; To Repurchase GSK’s Entire Holdings

By Vandana Singh

September 19, 2:28 PM

Theravance Biopharma Inc (NASDAQ:TBPH) is buying back over 9.6 million shares from GSK plc (NYSE:GSK) for roughly $94 million, according to an…

GSK

1 minute read

HC Wainwright Sees 40% Upside For This Once Battered Stock With Pipeline Turnaround

By Vandana Singh

September 19, 2:02 PM

HC Wainwright is assuming coverage on AnaptysBio Inc (NASDAQ:ANAB) with a Buy Rating and a price target of $35 at a unique inflection…

ANAB

1 minute read

Genfit To Buy This Swiss Firm Expanding Its Portfolio in Liver Diseases

By Vandana Singh

September 19, 12:42 PM

Genfit SA (NASDAQ:GNFT) has agreed to acquire the Swiss startup Versantis for CHF40 million upfront in a small-time buyout. The deal,…

GNFT

1 minute read

Veru Announces FDA Has Rescheduled The Meeting Date To Nov. 9 For The Advisory Committee To Review Emergency Use Authorization For Sabizabulin For Hospitalized COVID-19 Patients At High Risk For Acute Respiratory Distress Syndrome; No Change In Agenda

By Benzinga Newsdesk

September 19, 12:19 PM

MIAMI, Sept. 19, 2022 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ:VERU), a biopharmaceutical company focused on developing novel medicines for COVID-19 and other viral and ARDS-related diseases and for the management of breast

VERU

1 minute read

Beam Therapeutics Touts Encouraging Preclinical Data From Gene Editing Approach For Hepatitis B Infection

By Vandana Singh

September 19, 11:49 AM

Beam Therapeutics Inc (NASDAQ:BEAM) announced new preclinical data demonstrating the potential of its multiplex base editing approach to reduce hepatitis B…

BEAM

1 minute read

After US Study, Pfizer’s 20-Valent Pneumococcal Jab Aces European Infant Study

By Vandana Singh

September 19, 11:46 AM

Pfizer Inc (NYSE:PFE) announced positive topline results from its European Phase 3 study in infants evaluating its 20-valent pneumococcal conjugate vaccine…

PFE

1 minute read

Europe Approves First Bispecific Antibody From Roche For Two Eye Disorders

By Vandana Singh

September 19, 10:40 AM

The European Commission approved Roche Holding AG’s (OTC:RHHBY) Vabysmo (faricimab) for neovascular or ‘wet’ age-related macular degeneration (nAMD) and visual impairment…

REGN

1 minute read

European Authority Backs AbbVie’s Crohn’s Disease Candidate

By Vandana Singh

September 19, 9:43 AM

The European Medicines Agency’s Committee for Medicinal Products for Human Use has adopted a positive opinion recommending approval of AbbVie Inc’s (NYSE:ABBV)…

ABBV